We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current DIM market cap is 18.04B. The company's latest EPS is EUR 1.7990 and P/E is 103.50.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 1.91B | 2.89B | 3.49B | 2.78B | 2.78B |
| Operating Income | 470M | 854.78M | 1.04B | 463.3M | 369.9M |
| Net Income | 335.93M | 414.41M | 876.1M | 310.3M | 175.1M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 2.86B | 3.95B | 5.07B | 7.73B | 8.26B |
| Total Liabilities | 1.4B | 2.22B | 2.55B | 5.06B | 4.23B |
| Total Equity | 1.46B | 1.73B | 2.51B | 2.67B | 4.02B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 416.88M | 695.97M | 612.3M | 746.4M | 815M |
| Investing | -621.12M | -465.23M | -957.5M | -2.72B | -339.9M |
| Financing | 234.07M | -71.71M | 220.7M | 1.99B | 84.9M |
| Market Cap | 18.04B |
| Price to Earnings Ratio | 103.50 |
| Price to Sales Ratio | 6.52 |
| Price to Cash Ratio | 26.69 |
| Price to Book Ratio | 4.5 |
| Dividend Yield | 0.37% |
| Shares Outstanding | 97.33M |
| Average Volume (1 week) | 84.05k |
| Average Volume (1 Month) | 71.27k |
| 52 Week Change | -30.84% |
| 52 Week High | 281.00 |
| 52 Week Low | 139.10 |
| Spread (Intraday) | 0.1 (0.05%) |
| Company Name | Sartorius Stedim Biotech SA |
| Address |
zone industrielle les paluds avenue de jouques marseille, bouches-du-rhone 13781 |
| Website | https://www.sartorius.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
